Innate Pharma (IPHA) Payables (2017 - 2026)
Innate Pharma (IPHA) recorded Payables of $13.1 million in the quarter ended Jun 30, 2026, down 3.9% from $13.63 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Payables (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma reported Payables of $16.99 million, down 1.9% from the prior year.
- Annual Payables has declined for seven straight years, with a five-year compound annual growth rate of -12.8% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Payables came in at $17.32 million in the year ended Dec 31, 2024 (-5.9%), $18.41 million in the year ended Dec 31, 2023 (-16.5%), $22.04 million in the year ended Dec 31, 2022 (-32.6%) and $32.69 million in the year ended Dec 31, 2021 (-3.1%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Payables in data going back to the quarter ended Dec 31, 2017.
- On a year-over-year basis, Payables rose in 1 of the last four quarters, with an average decline of 7.1%.
- Peak year-over-year performance for Payables in the last five years was growth of 3.8% in the quarter ended Jun 30, 2023, against a decline of 34.7% in the quarter ended Dec 31, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | 13.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.10 Mn |
| Dec 31, 2025 | 17.51 Mn |
| Jun 30, 2025 | 13.63 Mn |
| Dec 31, 2024 | 17.11 Mn |
| Jun 30, 2024 | 17.09 Mn |
| Dec 31, 2023 | 18.31 Mn |
| Jun 30, 2023 | 20.68 Mn |
| Dec 31, 2022 | 21.33 Mn |
| Jun 30, 2022 | 19.92 Mn |
| Dec 31, 2021 | 32.69 Mn |
| Jun 30, 2021 | 20.50 Mn |
| Dec 31, 2020 | 35.22 Mn |
| Jun 30, 2020 | 26.54 Mn |
| Dec 31, 2019 | 54.80 Mn |
| Dec 31, 2018 | 104.61 Mn |
| Dec 31, 2017 | 29.03 Mn |
API Access
Innate Pharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();